数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Christopher J. Turnbull 男 Independent Director 70 未披露 30.55 2025-12-30
Peter M. Buonomo 男 Director and Senior Vice President 65 13.10万美元 20.00 2025-12-30
Todd C. Johnson 男 Independent Director 48 未披露 75.03 2025-12-30
Timothy G. Laske 男 Independent Director 62 未披露 未持股 2025-12-30
Joseph A. Marino 男 Chairman of the Board and Chief Executive Officer and President 74 18.49万美元 189.34 2025-12-30

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Peter M. Buonomo 男 Director and Senior Vice President 65 13.10万美元 20.00 2025-12-30
Scott S. Robinson 男 Treasurer and Vice President, Finance 46 15.46万美元 10.00 2025-12-30
Joseph A. Marino 男 Chairman of the Board and Chief Executive Officer and President 74 18.49万美元 189.34 2025-12-30

董事简历

中英对照 |  中文 |  英文
Christopher J. Turnbull

Christopher J. Turnbull自2018年起担任公司董事。自Cardia,Inc.于1998年成立以来,Turnbull先生一直担任该公司的董事。从1993年到1997年,Turnbull先生是St. Paul Medical,Inc.的董事长兼首席执行官,该公司是一家医疗设备制造商,生产感染控制市场的产品。他曾于2001年至2003年担任T Medical,Inc.的董事长兼首席执行官,该公司是一家先进气道管理程序产品ed的医疗设备制造商。他于1986年至2003年创立并担任宾夕法尼亚州重症护理麻醉师公司的首席执行官。2005年至2015年,他担任Owatonna Anesthesia Services P.A.的首席执行官。2015年,他创立了Minnesota Anesthesia Associates,PLC(MAA)并担任其首席执行官至2020年。从2015年到2017年,Turnbull先生还为明尼苏达州罗切斯特市的梅奥诊所提供麻醉服务。从2017年到2020年,Turnbull先生担任双城手术中心的首席CRNA。Turnbull先生在护士麻醉实践40年后于2020年退休。Turnbull先生于1979年毕业于圣玛丽护士麻醉学学院,并于1980年成为董事会认证的注册护士麻醉师(CRNA)。


Christopher J. Turnbull has served as a Director of the Company since 2018. Mr. Turnbull has served as a Director of Cardia, Inc. since the company's incorporation in 1998. From 1993 to 1997, Mr. Turnbull was the Chairman and CEO of St. Paul Medical, Inc., a medical device manufacturer of products ed in the infection control marketplace. He served as Chairman and CEO of T Medical, Inc., from 2001 to 2003, a medical device manufacturer of products ed in advanced airway management procedures. He founded and served as CEO of Critical Care Anesthetists, PA from 1986 to 2003. From 2005 to 2015, he served as CEO of Owatonna Anesthesia Services P.A. In 2015, he founded and served as CEO of Minnesota Anesthesia Associates, PLC (MAA) until 2020. From 2015 to 2017, Mr. Turnbull also provided anesthesia services to the Mayo Clinic in Rochester, Minnesota. From 2017 to 2020, Mr. Turnbull served as the lead CRNA for Twin Cities Surgery Center. Mr. Turnbull retired in 2020 after 40 years of Nurse Anesthesia practice. Mr. Turnbull graduated from Saint Mary's School of Nurse Anesthesiology in 1979 and became a Board Certified Registered Nurse Anesthetist (CRNA) in 1980.
Christopher J. Turnbull自2018年起担任公司董事。自Cardia,Inc.于1998年成立以来,Turnbull先生一直担任该公司的董事。从1993年到1997年,Turnbull先生是St. Paul Medical,Inc.的董事长兼首席执行官,该公司是一家医疗设备制造商,生产感染控制市场的产品。他曾于2001年至2003年担任T Medical,Inc.的董事长兼首席执行官,该公司是一家先进气道管理程序产品ed的医疗设备制造商。他于1986年至2003年创立并担任宾夕法尼亚州重症护理麻醉师公司的首席执行官。2005年至2015年,他担任Owatonna Anesthesia Services P.A.的首席执行官。2015年,他创立了Minnesota Anesthesia Associates,PLC(MAA)并担任其首席执行官至2020年。从2015年到2017年,Turnbull先生还为明尼苏达州罗切斯特市的梅奥诊所提供麻醉服务。从2017年到2020年,Turnbull先生担任双城手术中心的首席CRNA。Turnbull先生在护士麻醉实践40年后于2020年退休。Turnbull先生于1979年毕业于圣玛丽护士麻醉学学院,并于1980年成为董事会认证的注册护士麻醉师(CRNA)。
Christopher J. Turnbull has served as a Director of the Company since 2018. Mr. Turnbull has served as a Director of Cardia, Inc. since the company's incorporation in 1998. From 1993 to 1997, Mr. Turnbull was the Chairman and CEO of St. Paul Medical, Inc., a medical device manufacturer of products ed in the infection control marketplace. He served as Chairman and CEO of T Medical, Inc., from 2001 to 2003, a medical device manufacturer of products ed in advanced airway management procedures. He founded and served as CEO of Critical Care Anesthetists, PA from 1986 to 2003. From 2005 to 2015, he served as CEO of Owatonna Anesthesia Services P.A. In 2015, he founded and served as CEO of Minnesota Anesthesia Associates, PLC (MAA) until 2020. From 2015 to 2017, Mr. Turnbull also provided anesthesia services to the Mayo Clinic in Rochester, Minnesota. From 2017 to 2020, Mr. Turnbull served as the lead CRNA for Twin Cities Surgery Center. Mr. Turnbull retired in 2020 after 40 years of Nurse Anesthesia practice. Mr. Turnbull graduated from Saint Mary's School of Nurse Anesthesiology in 1979 and became a Board Certified Registered Nurse Anesthetist (CRNA) in 1980.
Peter M. Buonomo

Peter M. Buonomo自2025年起担任公司高级副总裁,自2025年起担任董事。Previoly,2018年至今担任公司销售和营销副总裁。从1998年到2023年,他担任Cardia,Inc.的销售和营销副总裁和公司官员。从1994年到1998年,Buonomo先生担任Applied Biometrics,Inc.的营销总监和销售和营销副总裁,Applied Biometrics,Inc.是一家上市医疗设备制造商。Buonomo先生于1983年毕业于口腔罗伯茨大学,获得BINESS理学学士学位,随后他于1984年完成了同样在口腔罗伯茨大学的MBA学位。


Peter M. Buonomo has served as Senior Vice President of the Company since 2025 and as a director since 2025. Previoly, he was Vice President of Sales and Marketing at the Company from 2018 to present. From 1998 to 2023, he was the VP of Sales and Marketing and a Corporate Officer at Cardia, Inc. From 1994 to 1998, Mr. Buonomo was the Director of Marketing and VP of Sales and Marketing at Applied Biometrics, Inc., a publicly held medical device manufacturer. Mr. Buonomo graduated from Oral Roberts University in 1983 with a Bachelor of Science in Biness, he nt on to complete his MBA, also at Oral Roberts University, in 1984.
Peter M. Buonomo自2025年起担任公司高级副总裁,自2025年起担任董事。Previoly,2018年至今担任公司销售和营销副总裁。从1998年到2023年,他担任Cardia,Inc.的销售和营销副总裁和公司官员。从1994年到1998年,Buonomo先生担任Applied Biometrics,Inc.的营销总监和销售和营销副总裁,Applied Biometrics,Inc.是一家上市医疗设备制造商。Buonomo先生于1983年毕业于口腔罗伯茨大学,获得BINESS理学学士学位,随后他于1984年完成了同样在口腔罗伯茨大学的MBA学位。
Peter M. Buonomo has served as Senior Vice President of the Company since 2025 and as a director since 2025. Previoly, he was Vice President of Sales and Marketing at the Company from 2018 to present. From 1998 to 2023, he was the VP of Sales and Marketing and a Corporate Officer at Cardia, Inc. From 1994 to 1998, Mr. Buonomo was the Director of Marketing and VP of Sales and Marketing at Applied Biometrics, Inc., a publicly held medical device manufacturer. Mr. Buonomo graduated from Oral Roberts University in 1983 with a Bachelor of Science in Biness, he nt on to complete his MBA, also at Oral Roberts University, in 1984.
Todd C. Johnson

Todd C. Johnson自2021年起担任公司董事,并由公司A轮股东任命。过去15年,约翰逊先生一直担任财务规划和健康管理公司Cedar Point Capital,LLC的首席合规官。在担任现职之前,约翰逊曾在Stifel Nicola的明尼阿波利斯私募部门工作,协助定价、配售和完成私募投资。Johnson先生还担任HRA IQ,Inc.的董事会成员以及RXFunction和Medicom Health Interactive董事会的观察员。2000年,约翰逊先生毕业于德克萨斯州达拉斯的南方卫理公会大学,获得金融理学学士学位。


Todd C. Johnson has served as a Director of the Company since 2021 and was appointed to the role by the Company's Series A shareholders. Mr. Johnson has served as the Chief Compliance Officer of Cedar Point Capital, LLC, a securities investment firm, for the past 18 years. Prior to his current role, Mr. Johnson worked in the Minneapolis Private Placement Department at Stifel Nicola, where he assisted in pricing, placing, and closing private placement investments. Mr. Johnson also serves as a board member of Lifelens Technologies, a privately held company and an observer on the board of RxFunction, Inc. In 2000, Mr. Johnson graduated from Southern Methodist University in Dallas, Texas, with a Bachelor of Science in Finance.
Todd C. Johnson自2021年起担任公司董事,并由公司A轮股东任命。过去15年,约翰逊先生一直担任财务规划和健康管理公司Cedar Point Capital,LLC的首席合规官。在担任现职之前,约翰逊曾在Stifel Nicola的明尼阿波利斯私募部门工作,协助定价、配售和完成私募投资。Johnson先生还担任HRA IQ,Inc.的董事会成员以及RXFunction和Medicom Health Interactive董事会的观察员。2000年,约翰逊先生毕业于德克萨斯州达拉斯的南方卫理公会大学,获得金融理学学士学位。
Todd C. Johnson has served as a Director of the Company since 2021 and was appointed to the role by the Company's Series A shareholders. Mr. Johnson has served as the Chief Compliance Officer of Cedar Point Capital, LLC, a securities investment firm, for the past 18 years. Prior to his current role, Mr. Johnson worked in the Minneapolis Private Placement Department at Stifel Nicola, where he assisted in pricing, placing, and closing private placement investments. Mr. Johnson also serves as a board member of Lifelens Technologies, a privately held company and an observer on the board of RxFunction, Inc. In 2000, Mr. Johnson graduated from Southern Methodist University in Dallas, Texas, with a Bachelor of Science in Finance.
Timothy G. Laske

Timothy G. Laske自2025年起担任公司董事。Laske先生目前担任美敦力心脏消融解决方案Biness的研发副总裁,自2024年以来一直担任该职务,他是美敦力 Bakken研究员、技术研究员以及美国医学和生物工程研究所研究员。他之前在美敦力担任的职务包括AF解决方案研究和Biness开发副总裁、心脏瓣膜高级产品开发总监、经导管心脏瓣膜高级项目总监、心律治疗交付技术总监以及vario技术管理和设计工程职位。在美敦力任职31年之前,他曾在福特汽车公司担任设计工程师。他拥有密歇根理工大学的学士学位、密歇根大学的硕士学位,以及明尼苏达大学的生物医学工程博士学位,担任外科系的兼职助理教授。


Timothy G. Laske has served as a Director of the Company since 2025. Mr. Laske is currently Vice President of Research & Development for the Cardiac Ablation Solutions Biness at Medtronic, a role he has held since 2024. He is a Medtronic Bakken Fellow, a Technical Fellow, and a Fellow of the American Institute for Medical and Biological Engineering. His previo roles at Medtronic include VP of Research and Biness Development for AF Solutions, Senior Product Development Director for Heart Valves, Senior Program Director for Transcatheter Heart Valves, Technology Director for Cardiac Rhythm Therapy Delivery, and vario technology management and design engineering positions. Prior to his 32 year tenure at Medtronic, he worked as a Design Engineer at Ford Motor Company. He has a B.S. degree from Michigan Technological University, an M.S. from the University of Michigan, and a Ph.D. in Biomedical Engineering from the University of Minnesota, where he serves as an Adjunct Assistant Professor in the Department of Surgery.
Timothy G. Laske自2025年起担任公司董事。Laske先生目前担任美敦力心脏消融解决方案Biness的研发副总裁,自2024年以来一直担任该职务,他是美敦力 Bakken研究员、技术研究员以及美国医学和生物工程研究所研究员。他之前在美敦力担任的职务包括AF解决方案研究和Biness开发副总裁、心脏瓣膜高级产品开发总监、经导管心脏瓣膜高级项目总监、心律治疗交付技术总监以及vario技术管理和设计工程职位。在美敦力任职31年之前,他曾在福特汽车公司担任设计工程师。他拥有密歇根理工大学的学士学位、密歇根大学的硕士学位,以及明尼苏达大学的生物医学工程博士学位,担任外科系的兼职助理教授。
Timothy G. Laske has served as a Director of the Company since 2025. Mr. Laske is currently Vice President of Research & Development for the Cardiac Ablation Solutions Biness at Medtronic, a role he has held since 2024. He is a Medtronic Bakken Fellow, a Technical Fellow, and a Fellow of the American Institute for Medical and Biological Engineering. His previo roles at Medtronic include VP of Research and Biness Development for AF Solutions, Senior Product Development Director for Heart Valves, Senior Program Director for Transcatheter Heart Valves, Technology Director for Cardiac Rhythm Therapy Delivery, and vario technology management and design engineering positions. Prior to his 32 year tenure at Medtronic, he worked as a Design Engineer at Ford Motor Company. He has a B.S. degree from Michigan Technological University, an M.S. from the University of Michigan, and a Ph.D. in Biomedical Engineering from the University of Minnesota, where he serves as an Adjunct Assistant Professor in the Department of Surgery.
Joseph A. Marino

Joseph A. Marino。自1998年起担任Cardia, Inc.(医疗设备制造商)的总裁和行政总裁。


Joseph A. Marino has served as Chairman of the Board of Directors since 2018 and President & Chief Executive Officer of the Company since 2024. Mr. Marino has served as Chairman of the Board of Directors and Chief Executive Officer of Cardia, Inc. since 1998. He currently serves as Chairman of the Board of Directors of Electro Sensors, Inc. (NASDAQ: ELSE), a publicly held company that designs and manufactures hazard monitoring systems for indtrial applications. He has served on the Electro Sensors board since 1996 and has served as its Chairman since 2013. From 1994 to 1998, Mr. Marino served as the Chairman of the Board of Directors and Chief Executive Officer of Applied Biometrics, Inc., a publicly held manufacturer of medical devices. From 1980 to 1994, Mr. Marino served as Chairman of the Board of Directors and President and Chief Executive Officer of Biomedical Dynamics Corporation, a publicly held manufacturer of medical products. From 1977 to 1983, Mr. Marino served as Director and Department Head of vario clinical services at the University of Minnesota Hospitals. Mr. Marino graduated from the University of Minnesota with a Bachelor of Science degree in 1972.
Joseph A. Marino。自1998年起担任Cardia, Inc.(医疗设备制造商)的总裁和行政总裁。
Joseph A. Marino has served as Chairman of the Board of Directors since 2018 and President & Chief Executive Officer of the Company since 2024. Mr. Marino has served as Chairman of the Board of Directors and Chief Executive Officer of Cardia, Inc. since 1998. He currently serves as Chairman of the Board of Directors of Electro Sensors, Inc. (NASDAQ: ELSE), a publicly held company that designs and manufactures hazard monitoring systems for indtrial applications. He has served on the Electro Sensors board since 1996 and has served as its Chairman since 2013. From 1994 to 1998, Mr. Marino served as the Chairman of the Board of Directors and Chief Executive Officer of Applied Biometrics, Inc., a publicly held manufacturer of medical devices. From 1980 to 1994, Mr. Marino served as Chairman of the Board of Directors and President and Chief Executive Officer of Biomedical Dynamics Corporation, a publicly held manufacturer of medical products. From 1977 to 1983, Mr. Marino served as Director and Department Head of vario clinical services at the University of Minnesota Hospitals. Mr. Marino graduated from the University of Minnesota with a Bachelor of Science degree in 1972.

高管简历

中英对照 |  中文 |  英文
Peter M. Buonomo

Peter M. Buonomo自2025年起担任公司高级副总裁,自2025年起担任董事。Previoly,2018年至今担任公司销售和营销副总裁。从1998年到2023年,他担任Cardia,Inc.的销售和营销副总裁和公司官员。从1994年到1998年,Buonomo先生担任Applied Biometrics,Inc.的营销总监和销售和营销副总裁,Applied Biometrics,Inc.是一家上市医疗设备制造商。Buonomo先生于1983年毕业于口腔罗伯茨大学,获得BINESS理学学士学位,随后他于1984年完成了同样在口腔罗伯茨大学的MBA学位。


Peter M. Buonomo has served as Senior Vice President of the Company since 2025 and as a director since 2025. Previoly, he was Vice President of Sales and Marketing at the Company from 2018 to present. From 1998 to 2023, he was the VP of Sales and Marketing and a Corporate Officer at Cardia, Inc. From 1994 to 1998, Mr. Buonomo was the Director of Marketing and VP of Sales and Marketing at Applied Biometrics, Inc., a publicly held medical device manufacturer. Mr. Buonomo graduated from Oral Roberts University in 1983 with a Bachelor of Science in Biness, he nt on to complete his MBA, also at Oral Roberts University, in 1984.
Peter M. Buonomo自2025年起担任公司高级副总裁,自2025年起担任董事。Previoly,2018年至今担任公司销售和营销副总裁。从1998年到2023年,他担任Cardia,Inc.的销售和营销副总裁和公司官员。从1994年到1998年,Buonomo先生担任Applied Biometrics,Inc.的营销总监和销售和营销副总裁,Applied Biometrics,Inc.是一家上市医疗设备制造商。Buonomo先生于1983年毕业于口腔罗伯茨大学,获得BINESS理学学士学位,随后他于1984年完成了同样在口腔罗伯茨大学的MBA学位。
Peter M. Buonomo has served as Senior Vice President of the Company since 2025 and as a director since 2025. Previoly, he was Vice President of Sales and Marketing at the Company from 2018 to present. From 1998 to 2023, he was the VP of Sales and Marketing and a Corporate Officer at Cardia, Inc. From 1994 to 1998, Mr. Buonomo was the Director of Marketing and VP of Sales and Marketing at Applied Biometrics, Inc., a publicly held medical device manufacturer. Mr. Buonomo graduated from Oral Roberts University in 1983 with a Bachelor of Science in Biness, he nt on to complete his MBA, also at Oral Roberts University, in 1984.
Scott S. Robinson

Scott S. Robinson自2018年起担任公司财务主管和财务副总裁。Robinson先生在2010年至2018年期间担任Cardia,Inc.的财务总监。Robinson先生获得了爱荷华州立大学金融学MBA学位。


Scott S. Robinson has served as Treasurer and VP of Finance of the Company since 2018. Mr. Robinson served as Controller of Cardia, Inc. from 2010 until 2018. Mr. Robinson received an MBA in Finance from Iowa State University.
Scott S. Robinson自2018年起担任公司财务主管和财务副总裁。Robinson先生在2010年至2018年期间担任Cardia,Inc.的财务总监。Robinson先生获得了爱荷华州立大学金融学MBA学位。
Scott S. Robinson has served as Treasurer and VP of Finance of the Company since 2018. Mr. Robinson served as Controller of Cardia, Inc. from 2010 until 2018. Mr. Robinson received an MBA in Finance from Iowa State University.
Joseph A. Marino

Joseph A. Marino。自1998年起担任Cardia, Inc.(医疗设备制造商)的总裁和行政总裁。


Joseph A. Marino has served as Chairman of the Board of Directors since 2018 and President & Chief Executive Officer of the Company since 2024. Mr. Marino has served as Chairman of the Board of Directors and Chief Executive Officer of Cardia, Inc. since 1998. He currently serves as Chairman of the Board of Directors of Electro Sensors, Inc. (NASDAQ: ELSE), a publicly held company that designs and manufactures hazard monitoring systems for indtrial applications. He has served on the Electro Sensors board since 1996 and has served as its Chairman since 2013. From 1994 to 1998, Mr. Marino served as the Chairman of the Board of Directors and Chief Executive Officer of Applied Biometrics, Inc., a publicly held manufacturer of medical devices. From 1980 to 1994, Mr. Marino served as Chairman of the Board of Directors and President and Chief Executive Officer of Biomedical Dynamics Corporation, a publicly held manufacturer of medical products. From 1977 to 1983, Mr. Marino served as Director and Department Head of vario clinical services at the University of Minnesota Hospitals. Mr. Marino graduated from the University of Minnesota with a Bachelor of Science degree in 1972.
Joseph A. Marino。自1998年起担任Cardia, Inc.(医疗设备制造商)的总裁和行政总裁。
Joseph A. Marino has served as Chairman of the Board of Directors since 2018 and President & Chief Executive Officer of the Company since 2024. Mr. Marino has served as Chairman of the Board of Directors and Chief Executive Officer of Cardia, Inc. since 1998. He currently serves as Chairman of the Board of Directors of Electro Sensors, Inc. (NASDAQ: ELSE), a publicly held company that designs and manufactures hazard monitoring systems for indtrial applications. He has served on the Electro Sensors board since 1996 and has served as its Chairman since 2013. From 1994 to 1998, Mr. Marino served as the Chairman of the Board of Directors and Chief Executive Officer of Applied Biometrics, Inc., a publicly held manufacturer of medical devices. From 1980 to 1994, Mr. Marino served as Chairman of the Board of Directors and President and Chief Executive Officer of Biomedical Dynamics Corporation, a publicly held manufacturer of medical products. From 1977 to 1983, Mr. Marino served as Director and Department Head of vario clinical services at the University of Minnesota Hospitals. Mr. Marino graduated from the University of Minnesota with a Bachelor of Science degree in 1972.